The Technical University of Munich (TUM) is one of Europe’s leading universities in research and teaching. As the Entrepreneurial University, it doesn’t just want to understand the world – it wants to improve it. That is why the entire university revolves around one core goal: innovation.
Interdisciplinary solutions to future challenges
TUM’s unparalleled range of disciplines covers engineering and natural sciences, life sciences and medicine, management and social sciences – a combination found nowhere else in Europe. TUM leverages this enormous potential by intensively and intelligently combining the different subjects. This inspires modern fields of research extending from bioengineering to machine intelligence. At the same time, TUM links technological change more closely with social, political and ethical issues than other technical university.
Excellent career prospects for graduates
Its outstanding degree programs are strongly oriented towards research and, at the same time, tightly coupled to practical experience. Managers regularly choose TUM as one of the 10 best universities worldwide for the quality of graduates. (Global Employability University Rankings)
TUM offers amazing opportunities at every level of study and research – starting with the first semester right through to professorship. It invests more than other universities in the professional development of individual talent.
Awakening the entrepreneurial spirit
No other German university produces more start-up founders – the result of a support infrastructure unrivalled in Europe. TUM also builds long-term research partnerships with the most innovative global players. More and more companies are establishing roots directly on campus.
A global university
TUM is an international university with a high proportion of foreign students and researchers as well as more than 150 partner universities around the globe. With the founding of TUM Asia in 2012 in Singapore, it became the first German university to establish an overseas campus. TUM also has offices in Brussels, Cairo, Mumbai, Beijing, San Francisco, and São Paulo.
Among the top
TUM was awarded the title of “University of Excellence” in 2006 and 2012 in recognition of its innovative, dynamic culture. Far from resting on its laurels, though, TUM remains entrepreneurial – constantly striving to reach new heights.
Technical University of Munich (TUM) retains sole responsibility for content © 2019 Technical University of Munich (TUM).Portrait: Technical University of Munich – 150 Years culture of excellence
1 November 2017 - 31 October 2018
Subject/journal group: All
The table to the right includes counts of all research outputs for Technical University of Munich (TUM) published between 1 November 2017 - 31 October 2018 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Outputs by subject (FC)
Highlight of the month
Combo drug strategy for cancer
© Thomas Northcut/Getty
Targeting a critical signalling protein called SHP2 may augment the anti-tumour effects of a promising class of approved drugs known as MEK inhibitors.
A team led by Technical University of Munich researchers studied mouse models of lung and pancreatic cancer driven by altered forms of KRAS, a gene found mutated in many patients with these tumour types.
When the researchers blocked the activity of SHP2, either by genetic or pharmacological means, they saw delays in cancer progression.
SHP2 inhibition helped reduce levels of the mutant KRAS protein, but the treatment alone was insufficient to induce tumour regression. Only by adding an additional MEK-targeted drug could the researchers achieve tumour shrinkage in the mouse models. The synergistic drug combination also cut the risk of tumours developing resistance to the MEK inhibitor.
The findings highlight a compelling dual-drug strategy that merits further testing in clinical trials.
- Nature Medicine 24, 954–960 (2018). doi: 10.1038/s41591-018-0024-8
See more research highlights from Technical University of Munich (TUM)
1 Feb 2019
26 Dec 2018
31 Oct 2018
28 Sep 2018
29 Aug 2018
25 Jun 2018
29 May 2018
Top articles by Altmetric score in current window
Proceedings of the National Academy of Sciences of the United States of America
Search for High-energy Neutrinos from Binary Neutron Star Merger GW170817 with ANTARES, IceCube, and the Pierre Auger Observatory
The Astrophysical Journal Letters
1 November 2017 - 31 October 2018
International vs. domestic collaboration by FC
- 40.64% Domestic
- 59.36% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by FC (197 total)
- Technical University of Munich (TUM), Germany
- Domestic institution
Ludwig Maximilians University of Munich (LMU), Germany
Helmholtz Association of German Research Centres, Germany
Max Planck Society, Germany
University of Freiburg (Uni Freiburg), Germany
Leibniz Association, Germany
Dresden University of Technology (TU Dresden), Germany
University of Regensburg (UR), Germany
Wacker Chemie AG, Germany
University of Tübingen (Uni Tübingen), Germany
Heidelberg University (Uni Heidelberg), Germany
Top 10 international collaborators by FC (1803 total)
- Technical University of Munich (TUM), Germany
- Foreign institution
French National Centre for Scientific Research (CNRS), France
University of Cambridge, United Kingdom (UK)
Swiss Federal Institute of Technology in Lausanne (EPFL), Switzerland
Swiss Federal Institute of Technology Zurich (ETH Zurich), Switzerland
Catholic University of Louvain (UCL), Belgium
Harvard University, United States of America (USA)
National Institute for Nuclear Physics (INFN), Italy
Northwestern University (NU), United States of America (USA)
University of Zurich (UZH), Switzerland
University of Basel (UB), Switzerland
Note: Collaboration is determined by the fractional count (FC), which is listed in parentheses.
Affiliated joint institutions and consortia
- Heinz Maier-Leibnitz Zentrum (MLZ), Germany
- ALICE Collaboration, Switzerland
- Bavarian NMR Center (BNMRZ), Germany
- Belle Collaboration, Japan
- Bernstein Center for Computational Neuroscience Munich (BCCN), Germany
- Borexino Collaboration, Italy
- COMPASS Collaboration, Switzerland
- Center of Allergy and Environment (ZAUM), Germany
- Centre for Neural Engineering (CfNE), Australia
- Consortium for Refractive Error and Myopia (CREAM), Netherlands
- DZHK Partner Site Munich, Germany
- DZIF Partner Site Munich, Germany
- DZNE Site Munich, Germany
- Double Chooz Collaboration, France
- EchoGen Consortium, Netherlands
- Enriched Xenon Observatory (EXO), United States of America (USA)
- Global BPGen Consortium, United States of America (USA)
- HMGU Clinical Cooperation Group Antigen-specific Immunotherapy, Germany
- HMGU Clinical Cooperation Group Immune Monitoring, Germany
- Hall A Collaboration, United States of America (USA)
- Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health (HICE), Germany
- IceCube Collaboration, United States of America (USA)
- Institute for Biological and Medical Imaging (IBMI), Germany
- Institute of Silicon Chemistry at TU München, Germany
- Institute of Virology, Germany
- International Brachypodium Initiative (IBI), United States of America (USA)
- International Multiple Sclerosis Genetics Consortium (IMSGC), United States of America (USA)
- Munich GeoCenter (MGC), Germany
- Munich Heart Alliance (MHA), Germany
- Munich Quantum Center (QMC), Germany
- Straubing Centre of Science (WZS), Germany
- TUM CREATE, Singapore
- The AMD Gene Consortium, Germany
- The Cardiogenics Project, Germany
- The GERmanium Detector Array (GERDA), Italy
- The LAGUNA-LBNO Collaboration, Switzerland
- The QT Interval International GWAS Consortium (QT-IGC), United States of America (USA)
- Universitary Center of Health Sciences at Klinikum Augsburg (UNIKA-T), Germany
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.